marijuana stocks news

Aerogrow International, Inc. (AERO)

Income Statement Get Income Statement for:
View: Annual Data | Quarterly Data All numbers in thousands
Period Ending Dec 31, 2014 Sep 30, 2014 Jun 30, 2014 Mar 31, 2014
Total Revenue 10,980   1,707   1,683   2,588  
Cost of Revenue 7,635 1,083 1,144 1,605
Gross Profit 3,345   624   539   983  
Operating Expenses
Research Development 82 116 82 (103)
Selling General and Administrative 2,348 989 1,093 1,322
Non Recurring
Others
Total Operating Expenses
Operating Income or Loss 915   (481) (636) (236)
Income from Continuing Operations
Total Other Income/Expenses Net 371 11 (221) (1,915)
Earnings Before Interest And Taxes 1,286 (470) (857) (2,151)
Interest Expense 106 37 9
Income Before Tax 1,180 (507) (857) (2,160)
Income Tax Expense
Minority Interest
Net Income From Continuing Ops 1,180 (507) (857) (2,160)
Non-recurring Events
Discontinued Operations
Extraordinary Items
Effect Of Accounting Changes
Other Items
Net Income 1,180   (507) (857) (2,160)
Preferred Stock And Other Adjustments (152) 154 (240) (1,089)
Net Income Applicable To Common Shares 1,028   (353) (1,097) (3,249)

MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

$GWPH Announces Pricing of U.S. Public Offering

GW Pharmaceuticals plc Announces Pricing of U.S. Public Offering of ADSs Raising…

$CARA Selected to Present at the 2016 International Conference on Opioids

Cara Therapeutics Selected to Present at the 2016 International Conference on Opioids…

$GRCU Announces Dr. Trent Jones as New CEO

Green Cures & Botanical Distribution Inc., announces changes to the Executive Team…

GW Pharmaceuticals plc (GWPH) submits Type II Variation Application to the European Medicines Agency

GW Pharmaceuticals submits Type II Variation Application to the European Medicines Agency…